You Can Take Legal Action Against Fraudulent HIV Testing

RTB: The HIV Test scandal is reaching the courts. As the legal system begins to understand the fraudulent nature of HIV testing, we are seeing a first blush of what we predict will become a flood of lawsuits challenging the faulty, non-standardized “HIV positive” test diagnosis. If you have been given an ‘HIV’ diagnoses and wish to challenge it, please contact the OMSJ today.

BLT – A Washington man incorrectly diagnosed with HIV can sue his health clinic for infliction of emotional distress, the District of Columbia Court of Appeals ruled (PDF) today, expanding the ground for similar damages claims for the first time since 1990.

Zoe Tillman

BLT – Blog of the Legal Times

Although previous case law limited claims for emotional damages to cases in which a person was in physical danger and feared for his safety, the en banc court found that “physical endangerment” is too limiting a standard.

“Because care for the body and the emotions are so interlinked, and patients often are dependent on their physicians’ exercise of due care, they therefore are susceptible to suffer emotionally as well as physically as a result of their physicians’ negligence,” the judges wrote, noting the ruling is not limited to cases involving health care providers.

The judges, who ruled unanimously, expanded on the “zone of physical danger” requirement set up in the court’s 1990 Williams v. Baker decision.

The court’s new “supplemental rule” establishes a three-part test: First, the plaintiff has to show that the defendant’s obligation to the plaintiff is tied to the plaintiff’s emotional well-being; second, that there is an “especially likely” risk that negligence could cause “serious emotional distress;” and third, that negligent actions did cause that distress.

In the underlying case, Terry Hedgepeth went for an HIV test in late 2000 at the Whitman-Walker Clinic, now called Whitman-Walker Health, because he had just learned his girlfriend was HIV-positive. A blood test showed Hedgepeth was not HIV-positive but, due to a “human error,” the lab results form was filled out to mistakenly list him as positive.

Hedgepeth believed he was HIV-positive for the next five years. He suffered from severe depression and suicidal thoughts, and engaged in risky behavior, including sexual intercourse with a woman who was HIV-positive, because he thought “there was no reason for [him] to live.”

In June 2005, a series of new tests revealed he was not HIV-positive.  He filed suit against the nonprofit and one of its doctors in District of Columbia Superior Court in August 2005.

The trial judge granted the defendants summary judgment, finding that Hedgepeth had failed to pass the “zone of physical danger” test. The appeals court upheld the lower court’s decision in October 2009. Hedgepeth successfully requested an en banc rehearing, which was held last June.

The ruling today overturns the previous decisions and remands the case back to Superior Court.

Hedgepeth’s lawyer, Washington solo practitioner Jonathan Dailey, did not immediately return a request for comment. The Trial Lawyers Association of Metropolitan Washington, D.C., filed an amicus brief on Hedgepeth’s behalf; a representative there could not immediately be reached.

Alfred Belcuore, also a Washington solo practitioner, argued for Whitman-Walker Health. Belcuore and a spokesman for the nonprofit did not immediately return a request for comment. Children’s National Medical Center filed an amicus brief, but a representative there could not immediately be reached.

What do retroviruses do when pregnant? HIV is a retrovirus...

When we hear the word retrovirus, we think: Aids. The Human Immunodeficiency Virus or HIV is a retrovirus. HIV is what mainstream medicine tells us causes a number of different illnesses and weakening of immune defenses - Aids.

We test for the presence of this retrovirus, or rather for the "signature" of its proteins, and when we find those signatures we declare that the person suffers from Aids and better start treatment as soon as possible.

Pregnant mothers are tested with special attention. And where they are found to be positive, they are told that a course of anti-retroviral drugs will be needed to try and protect the baby from becoming infected as well.

Now this all seems very logical, until you find out that in the normal course of every pregnancy, retroviruses are activated and that those retroviruses have an active role in the construction of new blood vessels that are needed to allow the growing fetus to survive and develop.

Understanding HIV Testing, for Beginners

May 10, 2011 by Liam Scheff

RTB: HIV Tests have no standards, and come up positive for nearly every disease known to humankind, if you bother to read the medical literature on the subject. But this information is never offered to patients, or to the general public by the media.

What different tests are used to test for HIV? 

The implications of these facts are profound – millions and millions of people have been robbed of their lives, their freedom, health and medical choice by these absolutely fraudulent tests.

But all of this typically fails to convey the reality of receiving an unethical, but enforced “HIV diagnosis.” So, let us present our little play, here on RTB theater:

You Are Under Arrest, For Life (an HIV Test Parable)

The mainstream HIV/AIDS literature is replete with evidence that HIV/AIDS theory is wrong.

None so blind as those who WILL not see

Posted by Henry Bauer on 2011/06/26

The mainstream HIV/AIDS literature is replete with evidence that HIV/AIDS theory is wrong. Here’s a nice selection made by R. Crumb and obtained courtesy of Martin Barnes, from HIV and the Pathogenesis of AIDS by Jay Levy (3rd ed., 2007). Levy is one of the elders and gurus of HIV/AIDS matters, and he even claims to be a co-discoverer of HIV. Moreover, that his text is in its 3rd edition indicates that it has found favor among his peers. Yet it acknowledges as clearly as can be that there is actually no genuine evidence that HIV caused AIDS then or causes AIDS now:

UN HIV/AIDS Summit Results In Useless Statement

The UN HIV/AIDS summit June 8th to June 10th culminated in a watered-down political statement identifying key gaps in global HIV/AIDS policy. But it didn’t come up with any solutions or guidance how to remedy the matter. Cluelessness is a worldwide epidemic too, apparently.

Member states noted that:

“many national HIV prevention strategies inadequately focus on populations that epidemiological evidence shows are at higher risk, specifically men who have sex with men, people who inject drugs (IDUs) and sex workers, and further note, however, that each country should define the specific populations that are key to its epidemic and response, based on the epidemiological and national context.”

Thanks, UN! You rather succinctly said something that we all know—tweakers and prostitutes get HIV. We get it!

Essentially, the body said, “You member states have problems. Fix them. How? Uh… you figure it out.”

If the UN had drawn attention to the budget cuts undermining prevention programs worldwide, we could have broadened the discussion far more effectively.

Also, the UN could have included guidance for coalition-building across national lines on this deadly issue. How are UN experts and American scientists assisting, for instance, in sub-Saharan Africa? What solutions can first-world nations give developing countries? HIV/AIDS will only be properly addressed when global solutions are found for this global problem. Read More: 

A short poem, performed from the viewpoint of the falsely maligned HIV

Cancer, diabetes are becoming equal opportunity killers worldwide more so than HIV

Not long ago, the focus of medical humanitarian concern and aid in the developing world were communicable diseases like tuberculosis, malaria, typhoid and HIV/AIDS. And even though they still get the majority of press time, it turns out that these are no longer the major causes of death – not by a long stretch. by Dominika Osmolska Psy.D.
Read More:

HIV Transmission Myth: Denying Dr. Nancy Padian: 0 seroconversions!

Dr. Nancy Padian 10-year study on HIV transmission (paper: http://bit.ly/kA0FjO)

"We followed up 175 HIV-discordant couples [one partner tests positive, one negative] over time, for a total of approximately 282 couple-years of follow up... No transmission [of HIV] occurred among the 25% of couples who did not use their condoms consistently, nor among the 47 couples who intermittently practiced unsafe sex during the entire duration of follow-up..."

"We observed no seroconversions after entry into the study [nobody became HIV positive]...This evidence argues for low infectivity in the absence of either needle sharing and/or other cofactors."

Dr. Nancy Padian on HIV and sex. As part of her 10-year study on HIV transmission, she enrolled 175 couples, one partner HIV-positive, one HIV-negative. These individuals had sex -- vaginal and anal -- with and without condoms over the study period. They were continuously tested. Drug abusers were kept out of the study, to emphasize the role of sex in transmission.
The results: At the end of the study, how many people who tested negative became positive, after repeated sexual intercourse with their HIV-positive partners?
Was it 50?
Was it 25?
Was it 20?
No.
The answer is -- Zero. Zero people who tested negative became positive. From the study:
"We observed no seroconversions after entry into the study [nobody became HIV positive]...This evidence argues for low infectivity in the absence of either needle sharing and/or other cofactors."
Nancy Padian:
"I think HIV is more difficult to transmit than other sexually-transmitted -- than a lot of, probably most other sexually-transmitted diseases. I mean, I think that's pretty widely known."
Is it "pretty widely known," Doctor Padian?
It is now.

What do you know about AIDS and Sex? Who is Nancy Padian, and why is her study -- the longest and best on HIV transmission -- censored from the Wikipedia pages on both HIV and AIDS? Why does Dr. Padian's own Wikipedia page censor all of her findings?

Nancy Padian, PhD, MPH, is a professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco.
http://bit.ly/iuNtLf

David Rasnick is a PhD biochemist and a long time critic of the HIV=AIDS dogma

David Rasnick is a PhD biochemist and a long time critic of the HIV=AIDS dogma. He is a member of the board of Rethinking AIDS and was responsible for initiating its revitalization in 2005/6. He graduated from Georgia Tech with his PhD in 1978 based on research into proteases and his career was based on working with these enzymes. This gives him a unique insight into the drugs known as protease inhibitors introduced in the mid-1990s and a part of most HAART (Highly Active Antiretrovial Therapy) 'cocktails'.

Dr. Rasnick talks with Terry Michael and David Crowe for about an hour in an interview that ranges from science to politics to history to sociology and back again. For more information see David's personal website.
http://www.davidrasnick.com/David_Rasnick/Home.html

Here are some links for further exploration of the topics of the surrogate markers Viral Load and CD4 count as well as the AIDS drug AZT and the drug 'cocktails' known as HAART.
http://rethinkingaids.com/quotes/test-pcr.html
http://rethinkingaids.com/quotes/test-cd4.html
http://rethinkingaids.com/quotes/azt.html
http://rethinkingaids.com/quotes/haart.html

U.S. prosecutes more persons with HIV than any other country, study finds

By Marcos Restrepo | 06.09.11

The case of Daniel Hay Lewis, charged with criminal transmission of HIV by the Broward Sheriff’s Office, is not unusual. In fact, according to the executive director of the Center for HIV Law and Policy, the United States “prosecutes more people on the basis of their HIV status than any other country in the world.” 

Catherine Hanssens, the center’s executive director, writes in a email that “hundreds of HIV-positive people have been prosecuted and imprisoned for consensual sexual contact, frequently when no infection occurred, and for acts that didn’t and almost certainly wouldn’t have resulted in transmission.” 

Learning Lessons from an HIV Cure

By Jason Bardi on June 16, 2011

For doctors confronting the AIDS epidemic, past ambitions always boiled down to two main goals: prevention, or finding ways to protect people not yet exposed to HIV, through vaccines, safe sex education or other means; and treatment, or discovering effective drugs and providing them to people with HIV/AIDS, helping them live longer.

Now, thanks primarily to one test case, many doctors are beginning to think about a new possibility: finding a cure.

This case involved an American living in Germany, Timothy Brown, known popularly as the “Berlin patient,” Did science really cure the first case of HIV  whose infection appears to have been eradicated after two carefully planned bone marrow stem cell transplants in 2007 and 2008.

Jay Levy, MD, professor of medicine and co-discoverer of HIV, has renewed hope for finding a cure for HIV/AIDS.

“There’s no evidence of HIV in my body after three years, even though dozens of tests have been done to look for it,” said Brown, now a San Francisco Bay area resident and a patient at UCSF and San Francisco General Hospital (SFGH). To this day, Brown is believed to be the only person ever cured of HIV.

While experts agree that the procedure used to cure Brown is not generally applicable to the tens of millions living with HIV worldwide, his story has changed the thinking of many scientists at the forefront of HIV/AIDS research.

Several UCSF-affiliated researchers interviewed for this story pointed to Brown’s experience as a seminal shift, giving them renewed hope for the possibility of developing a cure.

HIV Vaccine Trial Highlights 30 Years of Progress

The University of Pennsylvania's HIV Prevention Research Division, also known as Philly Vax, is one of the 17 sites throughout the country where the study has been in progress for nearly two years. The current target for nationwide participants is 2,200 - at Philly Vax, that number is 118. None of the sites, however, have reached full capacity and are eagerly looking to accept new participants.
Ummm after 2 years only 118 people have volunteered. what does this say?

HIV Vaccine Trial Highlights 30 Years of Progress

Filed By Guest Blogger 

Kyle Bella

 | June 16, 2011 3:00 PM

On June 5, 1981 the medical community first announced the presence of a disease we now know as HIV/AIDS. Thirty years later, millions have died from the disease and many millions more live daily with the difficulties of treatment. Antiretrovirals have made AIDS manageable in many cases, greatly increasing quality of life and life expectancy of the infected. But limited access to these drugs, largely a result of cost, has helped fuel a reemergence of medical research aiming to develop an HIV vaccine. HVTN 505, one of the largest of these studies funded by the National Institutes of Health (NIH), is helping to fuel a sense of measured optimism in the fight against HIV.

The University of Pennsylvania's HIV Prevention Research Division, also known as Philly Vax, is one of the 17 sites throughout the country where the study has been in progress for nearly two years. The current target for nationwide participants is 2,200 - at Philly Vax, that number is 118. None of the sites, however, have reached full capacity and are eagerly looking to accept new participants.

Several years ago, I was browsing Facebook, and one of my friends posted a link to the PhillyVax site, which highlighted the general guidelines to participate. It stated plainly that you must be 18-50, HIV-negative, a male or male-to-female transgender person who is circumcised and who has sex with men 

The Death Sentence That Defined My Life

By MARK TRAUTWEIN

Published: June 4, 2011

I HAVEN’T died on schedule.

Most people don’t think death has a schedule, at least a knowable one. But if you were infected early in the AIDS epidemic, you thought otherwise. At 61, I have now lived half my life with AIDS, my constant companion and distant cousin, the inseparable identity I won’t let define me, the everyday fact and special circumstance that bent the arc of my life in every way.

Although there was not yet a test for the disease, I mark the beginning of my AIDS life in 1982. It’s hard to imagine now the intensity of sexual liberation that gripped gay men then. Oppression was out. Freedom was ours, and we declared it with sex.

World leaders adopt new targets to combat HIV

World leaders on Friday declared HIV "an unprecedented human catastrophe" and adopted new targets to combat the epidemic, including providing drug treatment to 15 million people by 2015,

MORE DRUGS!!!

A political declaration hammered out after seven weeks of difficult negotiations was adopted by consensus by the U.N. General Assembly at the end of a three-day high-level meeting to spotlight successes in tackling HIV/AIDS and the need to intensify the fight.

It commits the U.N.'s 192 member states to cut in half the transmission of HIV through sexual activity and injecting drugs by 2015 — and to ensure that all babies are born HIV-free by that date.

Is HIV the only causes in the drop in CD4 cells?

A 1998 article in Behavioural Ecology recently brought to HEAL London's attention has shed more light on both the incompetence of AIDS researchers in their claims to be able to measure immune system suppression due to HIV, and also blatant fraud in claiming that only HIV causes the drop in CD4 cells that is then labelled as 'AIDS'. In questioning whether or not testosterone has an immunosuppressive effect, the article points instead to immune system cell redistribution or relocation as the mechanism. A key section of the article of particular interest to HEAL London members says:

The immunoredistribution alternative

New insights into the immune response to stress offer an alternative explanation for the correlation between high levels of testosterone and changes in the immune system. We propose that leukocytes are temporarily shunted to different compartments of the immune system in response to testosterone, as they are in response to other steroids. This process, called immunoredistribution, would be easy to confuse with immunosuppression if immunity is assessed by leukocyte counts or if the measure of immunity is sampled at only one time or in only one tissue.

Probiotic Yogurt Consumption is Associated With an Increase of CD4 Count Among People Living With HIV/AIDS

Aim: To evaluate the long term effect of yogurt supplemented with Lactobacillus rhamnosusFiti on the immune function (CD4 count) of people living with HIV/AIDS.

Background: Gastrointestinal infections and the leakage of microbial products from the gut have a profound impact on the deterioration of the immune system among people living with HIV/AIDS. Among persons not infected with the virus, probiotics can prevent gastrointestinal infections and restore an effective gut barrier, suggesting they might have a beneficial effect on the immune function of people living with HIV/AIDS.

Study: We carried out an observational retrospective study over a period of 3 years, with longitudinal comparison of the CD4 count within participants (n=68) before and during probiotic yogurt consumption, and compared with a control group of participants not consuming the yogurt (n=82).

Results: Among the yogurt consumers before use and the nonconsumers, an average increase in CD4 count was seen of 0.13 cells/μL/day (95% CI; 0.07-0.20, P=<0.001). After commencing consumption, yogurt consumers experienced an additional increase of 0.28 cells/μL/day (95% CI; 0.10-0.46, P=0.003). When adjusting for length of time using antiretroviral medication, the additional increase explained by yogurt consumption remained 0.17 cells/μL/day (95% CI; 0.01-0.34, P=0.04). Treatment with antiretroviral medication was associated with an increase of 0.27 cells/μL/day (95% CI; 0.17-0.38, P=<0.001).

Conclusion: The introduction of probiotic yogurt, made by local women in a low-income community in Tanzania, was significantly associated with an increase in CD4 count among consumers living with HIV.

Journal of Clinical Gastroenterology:

October 2010 - Volume 44 - Issue 9 - pp e201-e205

Irvine, Stephanie L. BSc*; Hummelen, Ruben MSc† ‡; Hekmat, Sharareh PhD*; W. N. Looman, Caspar MSc†; Habbema, J. Dik F. PhD†; Reid, Gregor PhD, MBA‡ §

© 2010 Lippincott Williams & Wilkins, Inc.

Africa HIV patients reel from price rise - Al Jazeera English

Many cannot afford the food necessary to supplement their medication.

WATCH THE VIEDO

Rising food and fuel prices have brought new misery for people living with HIV in East Africa. Many of them are finding it hard to get the food necessary to supplement their medication.

Al Jazeera's Catherine Soi reports from Nairobi.

Office of National AIDS Policy, 30 years

What does it take to just the world "AND"?

it's AIDS and HIV not HIV/AIDS ....YOU DON"T die from AIDS....AIDS is a definition... AIDS and HIV are two different things.

Washington, D.C. – Thirty years ago this Sunday, the Centers for Disease Control and Prevention first reported on the condition that would eventually become known as human immunodeficiency virus (HIV) infection.  Over the past three decades, HIV has emerged as a potent global pandemic, and today more than 33 million people around the world are living with HIV and more than two million deaths from Acquired Immune Deficiency Syndrome (AIDS) annually.  Even today, more than 50,000 people in the United States are infected with HIV in the United States.

“We pause to mark the thirty years we have been fighting HIV/AIDS.” said President Barack Obama.  “As we remember people in our own lives we have lost and stand by those living with HIV/AIDS, we must also rededicate ourselves to finally ending this pandemic – in this country and around the world.”

Lifeboat: HIV - Daring to Share

The Lifeboat Project is a unique web-documentary that focuses on the experiences of families living in Europe as they come to terms with HIV/AIDS.

The Lifeboat Project is a living, online archive in which five families, living in Europe, talk candidly about many taboo subjects: love, sex, pain, secrecy and ways of coping in a world that can be very judgemental. Stigma is still a big problem, even in Europe. Our films are being shown internationally at the grass roots level, in hospitals as part of psycho-social support, in educational programmes and in global AIDS campaigns.

Who wants to go?

Weho Residents to Dramatize HIV's Personal Side with 'Infection Monologues'

Set for this weekend’s 30th anniversary of the first AIDS diagnosis, the play blends drama and humor in portraying a diverse group of men living with the virus. Read more:

The Infection Monologues	Renberg Theatre	Saturday, 6/4/11 7:00PM PDT	Buy Tickets
The Infection Monologues	Renberg Theatre	Sunday, 6/5/11 7:00PM PDT	Buy Tickets

Anthony Fauci reflects on 30 years of AIDS

Anthony S. Fauci, MD, is arguably the U.S. government’s best-known scientist. While he has testified to Congress on more than 200 occasions and interacted with every U.S. president since Ronald Reagan on a variety of issues, he is known most for his work on HIV/AIDS. He was appointed Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH) in 1984, and oversees an extensive research portfolio of basic and applied research to prevent, diagnose, and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism.

Diagnosing HIV without using an HIV Test 

John Donnelly interviewed Dr. Fauci for Science Speaks’ series on the 30^thanniversary since the discovery of a virus that would turn out to be HIV, and he talked about everything from how he first learned of the disease, to his surprise in President George W. Bush’s commitment, to the unmet needs today to fight the pandemic.

History of Gilead Sciences makers of "treatments of HIV"

Some interesting reading, (well with Wikipedia sometimes you do have to read with between the lines). Still, who's been on the Broad and when...good to know who's mixing up all the HIV meds formulas uh?

Gilead Sciences (NASDAQ: GILD) is a biopharmaceutical company that discovers, develops and commercializes therapeutics. For many years since the company was founded, the company concentrated primarily on antiviral drugs to treat patients infected withHIV, hepatitis B or influenza. In 2006, Gilead acquired two companies that were developing drugs to treat patients with pulmonarydiseases. The company has fourteen commercially available products. Headquartered and founded in Foster City, California, Gilead has operations in North America, Europe and Australia. As of the end of 2009, the company had approximately 4,000 full-time employees.The company's name and logo refer to the Balm of Gilead. Gilead (a place mentioned in the Bible) was famed for its small trees that produced a resin used in medicine.

Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

History

Gilead Sciences was originally formed at Menlo Ventures under the name of "Oligogen, Inc." in August 1987 by H. DuBose Montgomery, co-founder of Menlo Ventures and Michael L. Riordan, a medical doctor who was 29 years old at the time. Riordan graduated from the Johns Hopkins University School of Medicine, spent a year as a consultant and then joined as an associate at Menlo Ventures in 1986. The company traces its roots to a runny nose because Montgomery got a particularly bad cold—a virus—and in his misery he wondered why so few antivirals existed when so many antibiotics were in use. The name of the company was changed to "Gilead Sciences" in 1988 and Montgomery served as the first Chairman of the Board from 1987 to 1993. Riordan looked to Donald Rumsfeld as a mentor in the business world and to navigate the political waters. Under the technical leadership of scientist Mark Matteucci, the company focussed on discovery research, making small strands of DNA (oligomers) to assess the potential of genetic code blockers (gene therapy). Its development of small molecule antiviral therapeutics was ushered in by John Martin in 1992 with the licensing of nucleotide compounds discovered in two European academic labs.